Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Ability of the Academic Research Consortium High Bleeding Risk Criteria in Patients Undergoing Percutaneous Coronary Intervention According to Body Mass Index.
Gao M, Spirito A, Sartori S, Vogel B, Gitto M, Oliva A, Smith KF, Sweeny J, Krishnan P, Moreno P, Krishnamoorthy PM, Kini A, Dangas G, Sharma SK, Mehran R. Gao M, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2024 Dec 24. doi: 10.1002/ccd.31322. Online ahead of print. Catheter Cardiovasc Interv. 2024. PMID: 39718124
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R. Chandrasekhar J, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E217-E225. doi: 10.1002/ccd.26716. Epub 2016 Sep 21. Catheter Cardiovasc Interv. 2017. PMID: 27650638
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Faggioni M, Baber U, Chandrasekhar J, Sartori S, Weintraub W, Rao SV, Vogel B, Claessen B, Kini A, Effron M, Ge Z, Keller S, Strauss C, Snyder C, Toma C, Weiss S, Aquino M, Baker B, Defranco A, Bansilal S, Muhlestein B, Kapadia S, Pocock S, Poddar KL, Henry TD, Mehran R. Faggioni M, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):53-60. doi: 10.1002/ccd.28033. Epub 2019 Jan 17. Catheter Cardiovasc Interv. 2019. PMID: 30656812
Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.
Chandrasekhar J, Dangas G, Baber U, Sartori S, Qadeer A, Aquino M, Vogel B, Faggioni M, Vijay P, Claessen BE, Goel R, Moreno P, Krishnan P, Kovacic JC, Kini A, Mehran R, Sharma S. Chandrasekhar J, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2020 Aug;96(2):298-308. doi: 10.1002/ccd.28841. Epub 2020 Mar 12. Catheter Cardiovasc Interv. 2020. PMID: 32162781
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Chen H, Spirito A, Sartori S, Nicolas J, Cao D, Zhang Z, Baber U, Kamaleldin K, Guthrie J, Vogel B, Sweeny J, Krishnan P, Sharma SK, Kini A, Dangas G, Mehran R. Chen H, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2023 Feb;101(3):511-519. doi: 10.1002/ccd.30569. Epub 2023 Jan 24. Catheter Cardiovasc Interv. 2023. PMID: 36691863
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Feldman D, Cao D, Sartori S, Zhang Z, Hengstenberg C, Tron C, Anthopoulos P, Widder JD, Meneveau N, Stella PR, Ferrari M, Jeger R, Violini R, Dumonteil N, Chen S, Yan R, Nicolas J, Razuk V, Spirito A, Vogel B, Mehran R, Dangas G. Feldman D, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2023 May;101(6):1134-1143. doi: 10.1002/ccd.30647. Epub 2023 Apr 10. Catheter Cardiovasc Interv. 2023. PMID: 37036268 Clinical Trial.
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
Jones D, Spirito A, Sartori S, Smith KF, Pivato CA, Chiarito M, Cao D, Nicolas J, Beerkens F, Edens M, Pileggi B, Sen A, Zhang Z, Vogel B, Sweeny J, Baber U, Dangas G, Sharma SK, Kini A, Mehran R. Jones D, et al. Among authors: vogel b. J Cardiol. 2023 Sep;82(3):179-185. doi: 10.1016/j.jjcc.2023.05.002. Epub 2023 May 13. J Cardiol. 2023. PMID: 37187289 Free article.
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
Spirito A, Cohen R, Sartori S, Vogel B, Baber U, Pileggi B, Smith K, Nicosia D, Kamaleldin K, Farhan S, Kini A, Sharma SK, Dangas G, Mehran R. Spirito A, et al. Among authors: vogel b. Catheter Cardiovasc Interv. 2024 Feb;103(3):425-434. doi: 10.1002/ccd.30960. Epub 2024 Feb 5. Catheter Cardiovasc Interv. 2024. PMID: 38314901
477 results